Silvia Formenti

Has grant

Cornell University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer

Open Date: 2024-10-01

Close Date: 2025-09-30

Grant: Close

Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer

Open Date: 2022-10-01

Close Date: 2023-09-30

Grant: Close

Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer

Open Date: 2019-10-01

Close Date: 2020-09-30

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Silvia Formenti

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Treatment deescalation for older women with favorable breast cancers: patient values and shared decision making

Heart and Left Anterior Descending Coronary Artery (LAD) Exposure from Hypo-Fractionated Whole Breast Radiotherapy with a Prone Setup

Biological Insights and Radiation–Immuno–Oncology Developments in Primary and Secondary Brain Tumors

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors

Emerging evidence for adapting radiotherapy to immunotherapy

Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer

Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer

Activin A Promotes Regulatory T-cell–Mediated Immunosuppression in Irradiated Breast Cancer

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer

Immunomodulation by anticancer cell cycle inhibitors.

Collaborators (5)

Selina Chen-Kiang

Lance Miller

Claire Vanpouille-Box

Sandra Demaria

Nils Rudqvist

Make your next move.